Intracerebroventricular Metformin Decreases Body Weight But Has Pro-oxidant Effects and Decreases Survival
Authors:
- Luis Valmor PortelaLPLuis Valmor Portela
- Jussania GnoattoJGJussania Gnoatto
- Andressa Wigner BrochierABAndressa Wigner Brochier
- Clarissa Branco HaasCHClarissa Branco Haas
- Adriano Martimbianco de AssisAdriano Martimbianco de Assis
- Gisele HanselGHGisele Hansel
- Eduardo Rigon ZimmerEZEduardo Rigon Zimmer
- Jean Pierre OsesJOJean Pierre Oses
- Alexandre Pastoris MullerAMAlexandre Pastoris Muller
- 10 December 2014
- journal article
- Published by Springer Nature in Neurochemical Research
- Vol. 40 (3) , 514-523
Abstract
Metformin (Met), which is an insulin-sensitizer, decreases insulin resistance and fasting insulin levels. The precise molecular target of Met is unknown; however, several reports have shown an inhibitory effect on mitochondrial complex I of the electron transport chain (ETC), which is a related site for reactive oxygen species production. In addition to peripheral effects, Met is capable of crossing the blood–brain barrier, thus regulating the central mechanism involved in appetite control. The present study explores the effects of intracerebroventricular (i.c.v.) infusion of Met on ROS production on brain, insulin sensitivity and metabolic and oxidative stress outcomes in CF1 mice. Metformin (Met 50 and 100 µg) was injected i.c.v. in mice daily for 7 days; the brain mitochondrial H2O2 production, food intake, body weight and fat pads were evaluated. The basal production of H2O2 of isolated mitochondria from the hippocampus and hypothalamus was significantly increased by Met (100 µg). There was increased peripheral sensitivity to insulin (Met 100 µg) and glucose tolerance tests (Met 50 and 100 µg). Moreover, Met decreased food intake, body weight, body temperature, fat pads and survival rates. Additionally, Met (1, 4 or 10 mM) decreased mitochondrial viability and increased the production of H2O2 in neuronal cell cultures. In summary, our data indicate that a high dose of Met injected directly into the brain has remarkable neurotoxic effects, as evidenced by hypothermia, hypoglycemia, disrupted mitochondrial ETC flux and decreased survival rate.Keywords
This publication has 34 references indexed in Scilit:
- Physical Exercise Exacerbates Memory Deficits Induced by Intracerebroventricular STZ but Improves Insulin Regulation of H2O2 Production in Mice SynaptosomesJournal of Alzheimer’s Disease, 2012
- Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive declineJournal of Clinical Investigation, 2012
- Markers for predicting death as an outcome for mice used in infectious disease research.2011
- The effect of an intracerebroventricular injection of metformin or AICAR on the plasma concentrations of melatonin in the ewe: potential involvement of AMPK?BMC Neuroscience, 2011
- Metabolic and behavioral effects of chronic olanzapine treatment and cafeteria diet in ratsBehavioural Pharmacology, 2010
- Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharidePharmacological Reports, 2010
- Sympathetic Modulation of the Host Defense Response to Infectious Challenge during Recovery from HemorrhageNeuroimmunomodulation, 2010
- Dietary omega-3 fatty acids attenuate cellular damage after a hippocampal ischemic insult in adult ratsThe Journal of Nutritional Biochemistry, 2010
- Subcellular distribution of metformin in rat liverJournal of Pharmacy and Pharmacology, 1991
- [44] Glutathione peroxidase1981